| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c97e5ad6260d10ef0dc9ef2c7e41ecf5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6459 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-72 |
| filingDate |
1984-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1987-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d65138e003ecb98154f051e8ca0fbce |
| publicationDate |
1987-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4661453-A |
| titleOfInvention |
Production of tissue plasminogen activator factor |
| abstract |
A process for the production of a tissue plasminogen activator obtained from cultured rat prostate adenocarcinoma cells. The techniques described lead to enhanced production of the tissue plasminogen activator for markedly prolonged periods of time. The tissue plasminogen activator so produced may be used for the treatment of thrombosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6083715-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5151359-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8810119-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9110447-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5472851-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6027888-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5134065-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5015583-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4889808-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5132214-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5183754-A |
| priorityDate |
1984-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |